The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research
Authors
Keywords
-
Journal
PLoS Neglected Tropical Diseases
Volume 13, Issue 12, Pages e0007787
Publisher
Public Library of Science (PLoS)
Online
2019-12-20
DOI
10.1371/journal.pntd.0007787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence-based guidelines for supportive care of patients with Ebola virus disease
- (2018) François Lamontagne et al. LANCET
- Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks
- (2018) Eric M. Espeland et al. PLoS Neglected Tropical Diseases
- Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak
- (2018) David Brett-Major et al. Viruses-Basel
- Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report
- (2017) Pierre-Stéphane Gsell et al. LANCET INFECTIOUS DISEASES
- Ethical challenges to responding to the Ebola epidemic: the World Health Organization experience
- (2016) Abha Saxena et al. Clinical Trials
- Trial design for evaluating novel treatments during an outbreak of an infectious disease
- (2016) John Whitehead et al. Clinical Trials
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Being Ready to Treat Ebola Virus Disease Patients
- (2015) David M. Brett-Major et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Next Epidemic — Lessons from Ebola
- (2015) Bill Gates NEW ENGLAND JOURNAL OF MEDICINE
- Human Ebola virus infection results in substantial immune activation
- (2015) Anita K. McElroy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
- (2015) Ben S. Cooper et al. PLOS MEDICINE
- Beyond Ebola: lessons to mitigate future pandemics
- (2015) Carlos Castillo-Chavez et al. Lancet Global Health
- Ebola Virus Disease in Health Care Workers — Guinea, 2014
- (2015) Margaret Grinnell et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Ebola Viral Hemorrhagic Disease Outbreak in West Africa- Lessons from Uganda.
- (2014) AK Mbonye et al. African Health Sciences
- Ebola: a crisis in global health leadership
- (2014) Lawrence O Gostin et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation